Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-04-22 @ 2:36 PM
Study NCT ID:
NCT06280716
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-15
First Post:
2024-02-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Organization: